Seegene Inc., a leading provider of molecular diagnostic solutions, will showcase its fully automated PCR testing system CURECA™ and data analysis platform STAgora™ at the current ADLM 2025 (Association for Diagnostics & Laboratory Medicine) in Chicago until July 31. According to Seegene, these technologies mark a turning point in global diagnostics.

CURECA™: Fully automated PCR testing

CURECA™ is the world’s first system to automate the entire PCR testing process – from sample preparation to nucleic acid extraction, amplification and data analysis – without manual intervention. Designed for 24/7 operation, it minimizes human error and increases the consistency and reliability of test results. Particularly outstanding is the automated preparation module, which revolutionizes the previously error-prone and labor-intensive sample pretreatment, especially for difficult materials such as stool. This reduces labor, increases throughput and allows professionals to focus on more complex tasks such as data analysis. The modular design allows flexible adaptation to different laboratory requirements and supports not only PCR but also other disciplines such as clinical chemistry and immunoassays, driving automation in the diagnostics market.

STAgora™: Real-time data analysis for precise diagnoses

The STAgora™ platform collects and analyzes real-time PCR data from hospitals worldwide and provides insights into infection trends, positivity rates and co-infections. With over 40 statistical tools, it enables the comparison of individual test results with regional epidemiologic data, promoting more precise, data-driven treatment strategies. STAgora™ improves the speed and accuracy of diagnoses and is considered an indispensable tool for clinical decision-making.

Global expansion and partnerships

Seegene plans to expand access to CURECA™ and STAgora™ through pilot projects and new partnerships. Following great interest at ESCMID Global 2025, the company is strengthening its presence in the US through subsidiaries such as Seegene Technologies and Seegene CURECA.

The innovations were announced on July 1, 2025 (STAgora™) and July 24, 2025 (CURECA™) and are set to transform diagnostics through efficiency, precision and global data integration.

Disclaimer

The product is currently in the pre-market launch phase. The configuration presented at ADLM 2025 is for demonstration purposes only and may differ in functionality, specification and components from the final commercial version. This material is intended solely to present the technology and does not constitute an advertisement for the sale of the product.

Editorial office: X-Press Journalistenbüro GbR

Gender note. The personal designations used in this text always refer equally to female, male and diverse persons. Double/triple references and gendered designations are avoided for the sake of better readability ected.